PT - JOURNAL ARTICLE AU - Saptorshi Gupta TI - Risk of lung cancer among welders and flame cutters: A Systematic Review and Meta-Analysis AID - 10.1101/2022.08.29.22279357 DP - 2022 Jan 01 TA - medRxiv PG - 2022.08.29.22279357 4099 - http://medrxiv.org/content/early/2022/08/30/2022.08.29.22279357.short 4100 - http://medrxiv.org/content/early/2022/08/30/2022.08.29.22279357.full AB - Background and Aim The process of flame-cutting and welding is believed to highly hazardous for workers involved in related industries. The study aims to provide a comprehensive quantitative effect of the risk of lung cancer due to exposure to welding fumes.Methods A systematic review was conducted to extract published estimates of odd’s ratio of the association of lung cancer and exposure to welding fumes, till 2022. Studies were extracted from the PubMed database with clearly defined inclusion and exclusion criteria. Studies from all parts of the world were considered. A meta-analysis with random effects model was conducted resulting in formation of forest plot, influence analysis, sensitivity analysis and checking for publication bias using a funnel plot.Results The meta-analysis yielded an OR of 1.256 (95% CI 1.055-1.496), with a moderately high heterogeneity between the studies (I2 = 68.78% ; τ2 = 0.039; Q = 36.115(p < 0.001)). The sensitivity and influence analysis confirmed the absence of highly influential studies that may have led to potentially distorted outcomes. The funnel plot showed no evidence of publication bias among the studies included in this analysis.Conclusion As the association of lung cancer and occupational hazards from exposure to welding fumes is certain, there is a need to control and regulate industrial activities that involve welding and flame cutting. Already, restrictions on safe levels of fume in workplace is in operation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.